Synopsis
Synopsis
0
API Suppliers
0
USDMF
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
Listed Suppliers
0
EDQM
0
USP
0
JP
0
Others
0
FDF Dossiers
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
US Patents
0
US Exclusivities
0
Health Canada Patents
US Medicaid
NA
Annual Reports
NA
Regulatory FDF Prices
NA
0
API
0
FDF
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
0
News #PharmaBuzz
1. Dipalmitoylhydroxyproline
2. Dipamitoylhydroxyproline
3. Trans-o, N-dipalmitoylhydroxyproline
4. E6aha53n1h
5. Lipacide Dphp
6. Sepilift Dphp
7. Ronacare Asc Iii
8. Einecs 255-490-0
9. Dtxsid60885734
10. Ec 255-490-0
11. O,n-dipalmitoylhydroxyproline
12. Trans-1-(1-oxohexadecyl)-4-((1-oxohexadecyl)oxy)-l-proline
13. Trans-1-(1-oxohexadecyl)-4-[(1-oxohexadecyl)oxy]-l-proline
14. L-proline, 1-(1-oxohexadecyl)-4-((1-oxohexadecyl)oxy)-, (4r)-
15. L-proline, 1-(1-oxohexadecyl)-4-((1-oxohexadecyl)oxy)-, Trans-
16. L-proline, 1-(1-oxohexadecyl)-4-[(1-oxohexadecyl)oxy]-, (4r)-
17. Refchem:588778
18. Dtxcid001025097
19. Dipalmitoyl Hydroxyproline [inci]
20. L-proline, 1-(1-oxohexadecyl)-4-(1-oxohexadecyl)oxy-, (4r)-
21. 41672-81-5
22. (2s,4r)-1-hexadecanoyl-4-hexadecanoyloxypyrrolidine-2-carboxylic Acid
23. Unii-e6aha53n1h
24. Schembl4403605
25. Qzlxcfqvoceksx-nochoarksa-n
26. Ns00008530
27. 672d815
28. Q27276932
| Molecular Weight | 607.9 g/mol |
|---|---|
| Molecular Formula | C37H69NO5 |
| XLogP3 | 14.1 |
| Hydrogen Bond Donor Count | 1 |
| Hydrogen Bond Acceptor Count | 5 |
| Rotatable Bond Count | 31 |
| Exact Mass | Da |
| Monoisotopic Mass | Da |
| Topological Polar Surface Area | 83.9 |
| Heavy Atom Count | 43 |
| Formal Charge | 0 |
| Complexity | 696 |
| Isotope Atom Count | 0 |
| Defined Atom Stereocenter Count | 2 |
| Undefined Atom Stereocenter Count | 0 |
| Defined Bond Stereocenter Count | 0 |
| Undefined Bond Stereocenter Count | 0 |
| Covalently Bonded Unit Count | 1 |
ABOUT THIS PAGE
47
PharmaCompass offers a list of Dipalmitoyl hydroxyproline API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, and more, enabling you to easily find the right Dipalmitoyl hydroxyproline manufacturer or Dipalmitoyl hydroxyproline supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Dipalmitoyl hydroxyproline manufacturer or Dipalmitoyl hydroxyproline supplier.
A Dipalmitoyl hydroxyproline manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Dipalmitoyl hydroxyproline, including repackagers and relabelers. The FDA regulates Dipalmitoyl hydroxyproline manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Dipalmitoyl hydroxyproline API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
A Dipalmitoyl hydroxyproline supplier is an individual or a company that provides Dipalmitoyl hydroxyproline active pharmaceutical ingredient (API) or Dipalmitoyl hydroxyproline finished formulations upon request. The Dipalmitoyl hydroxyproline suppliers may include Dipalmitoyl hydroxyproline API manufacturers, exporters, distributors and traders.
Dipalmitoyl hydroxyproline Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Dipalmitoyl hydroxyproline GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, and more, enabling you to easily find the right Dipalmitoyl hydroxyproline GMP manufacturer or Dipalmitoyl hydroxyproline GMP API supplier for your needs.
A Dipalmitoyl hydroxyproline CoA (Certificate of Analysis) is a formal document that attests to Dipalmitoyl hydroxyproline's compliance with Dipalmitoyl hydroxyproline specifications and serves as a tool for batch-level quality control.
Dipalmitoyl hydroxyproline CoA mostly includes findings from lab analyses of a specific batch. For each Dipalmitoyl hydroxyproline CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Dipalmitoyl hydroxyproline may be tested according to a variety of international standards, such as European Pharmacopoeia (Dipalmitoyl hydroxyproline EP), Dipalmitoyl hydroxyproline JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Dipalmitoyl hydroxyproline USP).
